Jennifer Mire
Internal Medicine · Natchez, MSNPI 1437520053
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 209 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 18.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,246 and has fallen 88.9% since, to $138 in 2025.
Across 209 payments — averaging $16.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$639
- Boehringer Ingelheim$380
- Johnson & Johnson$356
- GSK$311
- Merck$310
- Pfizer$289
- plus $1K from 18 others
What the payments were for
- Food & beverage$3,482100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 40 | $639 |
| Boehringer Ingelheim | 21 | $380 |
| Johnson & Johnson | 22 | $356 |
| GSK | 21 | $311 |
| Merck | 20 | $310 |
| Pfizer | 14 | $289 |
| AbbVie | 10 | $168 |
| Astellas Pharma US Inc | 10 | $165 |
| Amgen | 10 | $161 |
| Novartis | 10 | $153 |
| Sanofi-aventis U.S. LLC | 7 | $92 |
| Abbott | 4 | $83 |
| AstraZeneca | 5 | $74 |
| Tactile Systems Technology Inc | 1 | $48 |
| Edwards Lifesciences | 1 | $45 |
| Dexcom, Inc. | 3 | $44 |
| Biogen | 2 | $37 |
| E.r. Squibb & Sons, L.L.C. | 2 | $29 |
| Biocryst US Sales Co., LLC | 1 | $20 |
| CSL Behring | 1 | $18 |
| Abiomed | 1 | $17 |
| Phathom Pharmaceuticals, Inc. | 1 | $16 |
| Idorsia Pharmaceuticals US Inc | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $13 |
How this compares
$3,482 in reported general payments places this provider in the 80th percentile of 846 internal medicine providers in Mississippi.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 26 | $29,733 |
| EliquisApixaban | 19 | $23,518 |
| FarxigaDapagliflozin Propanediol | 12 | $6,872 |
| SymbicortBudesonide/Formoterol Fumarate | 16 | $5,560 |
| Valsartan | 65 | $2,391 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 16 | $1,489 |
| Rosuvastatin Calcium | 108 | $1,205 |
| Levothyroxine Sodium | 107 | $1,111 |
| Azelastine Hcl | 35 | $840 |
| Atorvastatin Calcium | 76 | $704 |
| Metformin Hcl ErMetformin Hcl | 46 | $663 |
| Pravastatin Sodium | 43 | $622 |
| Amlodipine Besylate | 112 | $567 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 18 | $546 |
| Losartan Potassium | 36 | $520 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $380 | $29,73326 claims |
| PfizerEliquis | $289 | $23,51819 claims |
| AstraZenecaFarxiga, Symbicort | $74 | $12,43228 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 846 internal medicine providers in Mississippi.
Other internal medicine in Natchez
- Edward DalyNatchez$11K
- Blane MireNatchez$8K
- Kenneth StubbsNatchez$8K
- Kelly WilkinsonJackson$79K
- Shanna PettieJackson$53K
- Gabriel HernandezJackson$41K
- Indira VeerisettyRidgeland$25K
- James BridgesMadison$23K
- Brendan RossJackson$19K
- Hassan CheemaJackson$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.